XOMA Royalty Corp — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Neal James R | CEO | Sale | 20,294 | $41.15 | $835,098 | 26,555 | Dec 15, 2020 |
| Hernday Natasha | — | Award / Grant | 4,000 | $25.00 | $100,000 | 4,000 | Dec 15, 2020 |
| BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | 15,000 | $4.03 | $60,450 | 21,555 | Dec 15, 2020 |
| PERRY MATTHEW D | — | Purchase | 200,000 | $25.00 | $5,000,000 | 200,000 | Dec 11, 2020 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 200,000 | $25.00 | $5,000,000 | 200,000 | Dec 11, 2020 |
| Neal James R | CEO | Sale | 6,448 | $32.46 | $209,302 | 21,275 | Nov 23, 2020 |
| BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | 6,875 | $4.03 | $27,706 | 13,430 | Nov 23, 2020 |
| Neal James R | CEO | Sale | 727 | $27.50 | $19,993 | 20,849 | Nov 5, 2020 |
| BURNS THOMAS M. | SVP, Finance & CFO | Sale | 726 | $27.50 | $19,965 | 6,555 | Nov 5, 2020 |
| BVF Partners OS Ltd. | — | Purchase | 4,991 | $18.45 | $92,084 | 1,743,503 | Sep 23, 2020 |
| BVF II GP LLC | — | Purchase | 3,907 | $18.77 | $73,334 | 2,011,017 | Sep 4, 2020 |
| BVF II GP LLC | — | Purchase | 922 | $19.17 | $17,675 | 1,710,079 | Sep 1, 2020 |
| BVF I GP LLC | — | Purchase | 1,607 | $19.32 | $31,047 | 1,701,734 | Aug 25, 2020 |
| BVF II GP LLC | — | Purchase | 3,496 | $19.70 | $68,871 | 1,966,028 | Aug 20, 2020 |
| BVF I GP LLC | — | Purchase | 4,050 | $17.34 | $70,227 | 1,938,665 | Aug 14, 2020 |
| BIOTECHNOLOGY VALUE FUND II LP | — | C | 596,813 | $13.00 | $7,758,569 | 1,700,127 | Apr 15, 2020 |
| BVF PARTNERS L P/IL | — | Purchase | 8,264 | $17.20 | $142,141 | 1,278,656 | Mar 25, 2020 |
| Neal James R | CEO | Purchase | 1,000 | $14.50 | $14,500 | 20,849 | Mar 23, 2020 |
| Neal James R | CEO | Purchase | 1,000 | $16.41 | $16,410 | 19,849 | Mar 20, 2020 |
| BIOTECHNOLOGY VALUE FUND II LP | — | Purchase | 4,439 | $14.52 | $64,454 | 1,270,392 | Mar 18, 2020 |
| BVF PARTNERS L P/IL | — | Purchase | 10,164 | $15.73 | $159,880 | 1,257,840 | Mar 13, 2020 |
| Neal James R | CEO | X | 1,180 | $22.00 | $25,960 | 18,849 | Dec 23, 2019 |
| LAMPERT MARK N | — | Purchase | 207,234 | $22.00 | $4,559,148 | 1,147,676 | Dec 19, 2019 |
| Neal James R | CEO | Sale | 4,348 | $22.00 | $95,656 | 17,669 | Nov 6, 2019 |
| Neal James R | Chief Executive Officer | Sale | 3,728 | $20.69 | $77,132 | 20,311 | Sep 18, 2019 |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | Sale | 3,829 | $21.96 | $84,085 | 6,555 | Sep 18, 2019 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 10,300 | $14.57 | $150,071 | 728,841 | May 14, 2019 |
| VAN NESS W DENMAN | — | Sale | 130 | $14.71 | $1,912 | — | May 10, 2019 |
| Neal James R | CEO | X | 678 | $13.00 | $8,814 | 21,011 | Dec 20, 2018 |
| VAN NESS W DENMAN | — | X | 800 | $13.00 | $10,400 | 9,944 | Dec 20, 2018 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 25,000 | $14.19 | $354,750 | 718,541 | Dec 17, 2018 |
| BVF INC/IL | — | Purchase | 9,400 | $14.50 | $136,300 | 666,478 | Dec 13, 2018 |
| BIOTECHNOLOGY VALUE FUND II LP | — | Purchase | 10,927 | $14.80 | $161,720 | 606,982 | Dec 10, 2018 |
| BVF PARTNERS L P/IL | — | Purchase | 4,823 | $14.85 | $71,622 | 591,078 | Dec 4, 2018 |
| BVF PARTNERS L P/IL | — | Purchase | 10,016 | $14.93 | $149,539 | 586,255 | Nov 27, 2018 |
| BIOTECHNOLOGY VALUE FUND L P | — | Purchase | 25,000 | $15.00 | $375,000 | 556,555 | Nov 20, 2018 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 21,141 | $13.31 | $281,387 | 473,453 | Nov 16, 2018 |
| VAN NESS W DENMAN | — | Sale | 5,528 | $12.67 | $70,040 | 9,144 | Nov 15, 2018 |
| Neal James R | CEO | Purchase | 4,000 | $13.26 | $53,040 | 20,333 | Nov 13, 2018 |
| BURNS THOMAS M. | SVP, Finance & CFO | Option Exercise | 2,655 | $5.50 | $14,603 | 9,210 | Apr 26, 2018 |
| Neal James R | CEO | Option Exercise | 15,655 | $5.50 | $86,103 | 31,988 | Apr 26, 2018 |
| BURNS THOMAS M. | SVP, Finance & CFO | Sale | 486 | $31.77 | $15,440 | 6,555 | Nov 14, 2017 |
| Neal James R | CEO | Sale | 2,200 | $27.44 | $60,368 | 16,333 | Nov 13, 2017 |
| Varian John | — | Sale | 39,540 | $6.24 | $246,730 | 2,344 | May 16, 2017 |
| Neal James R | VP Business Development | Sale | 5,105 | $5.40 | $27,567 | 15,366 | Mar 21, 2017 |
| BURNS THOMAS M. | VP, Finance & Chief Financial | Sale | 2,598 | $5.40 | $14,029 | 6,555 | Mar 21, 2017 |
| PERRY MATTHEW D | — | Award / Grant | 11,799 | — | — | 11,799 | Mar 2, 2017 |
| Neal James R | VP Business Development | Sale | 95 | $4.50 | $428 | 20,471 | Feb 1, 2017 |
| Neal James R | VP Business Development | Sale | 125 | $5.15 | $644 | 20,666 | Jan 9, 2017 |
| Varian John | — | Sale | 13,549 | $5.75 | $77,907 | 41,884 | Dec 21, 2016 |